Fol. Biol. 2002, 48, 43-50
https://doi.org/10.14712/fb2002048020043
DNA Vaccine against Friend Erythroleukaemia Virus
References
1. , H., Hunsmann, G. (1987) Synthetic vaccine against Friend virus induced erythroleukaemia: in vitro and in vivo studies with synthetic oligopeptides and sequence specific antisera. J. Gen. Virol. 68, 515-522.
<https://doi.org/10.1099/0022-1317-68-2-515>
2. , C., Okayama, H. (1987) High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7, 2745-2752.
3. , B., Miazawa, M., Britt, W. J. (1990) Host genetic control of spontaneous and induced immunity to Friend murine retrovirus infection. Annu. Rev. Immunol. 8, 477-499.
<https://doi.org/10.1146/annurev.iy.08.040190.002401>
4. , J. J., Ulmer, J. B., Shiver, J. W., Liu, M. A. (1997) DNA vaccines. Annu. Rev. Immunol. 10, 524-532.
5. , P. L., Moss, B., Morrison R. P., Wehrly, K., Nishio, J., Chesebro, B. (1986) T-lymphocyte priming and protection against Friend leukemia by vaccinia-retrovirus env gene recombinant. Science 234, 728-731.
<https://doi.org/10.1126/science.3490689>
6. , M., Proietti, E., Sandonato, L., Gabriele, L., Paretti, M., Plavec, O., Meyer, F., Kaido, T., Gresser, I., Belardelli, F. (1993) Alpha l-interferon gene transfer into metastatic Friend leukemia cells abrogated tumorigenicity in immunocompetent mice: antitumour therapy by means of interferon-producing cells. Cancer Res. 53, 1107-1112.
7. , S. E. (1999) HIV vaccines. Infect Dis. Clin. North Am. 13, 95-112.
<https://doi.org/10.1016/S0891-5520(05)70045-3>
8. , C. (1957) Cell-free transmission in adult Swiss mice of a disease having the character of a leukemia. J. Exp. Med. 105, 307-319.
<https://doi.org/10.1084/jem.105.4.307>
9. , A. (1999) HIV-1 DNA vaccines. Immunol. Lett. 65, 127-131.
<https://doi.org/10.1016/S0165-2478(98)00135-7>
10. , K. J., Chesebro, B. (1997) Immunity to retroviral infection. The Friend virus model. Proc. Natl. Acad. Sci USA 94, 7811-7816.
<https://doi.org/10.1073/pnas.94.15.7811>
11. K. J., Brooks, D. M., Robertson, M. N., Srinivas, R. V., Chesebro, B. (1997) Immunoprotective determinants in Friend murine leukemia virus envelope protein. Virology 248, 66-73.
<https://doi.org/10.1006/viro.1998.9264>
12. , C., Miyazawa, M., Nishio, J., Azuma, I., Chesebro, B. (1991) Use of low toxicity adjuvants and killed virus to induce protective immunity against the Friend murine leukemia retrovirus-induced disease. Vaccine 10, 353-356.
<https://doi.org/10.1016/0264-410X(92)90378-W>
13. , D. (1989) Molecular biology of Friend viral erythroleukaemia. Curr. Top. Microbiol. Immunol. 148, 1-42.
14. , C., Schneider, J., Bayer, H., Hunsmann, G. (1986) Immunoprevention of Friend leukemia virus-induced erythroleukaemia by vaccination with aggregated gp 70. J. Gen. Virol. 67, 1901-1907.
<https://doi.org/10.1099/0022-1317-67-9-1901>
15. , L., Altanerová, V., Altaner, Č., Boris-Lawrie, K. (1999) Bovine leukemia virus structural gene vectors are immunogenic and lack pathogenicity in a rabbit model. J. Virol. 73, 8160-8166.
<https://doi.org/10.1128/JVI.73.10.8160-8166.1999>
16. , P. J., Babiuk, L. A. (1999) DNA vaccines: a review. Adv. Virus Res. 54, 1129-1188.
17. , J. P., D'Andrea, A. D., Lodish, H. F., Baltimore, D. (1991) Activation of cell growth of Friend spleen focus-forming virus gp55 glycoprotein to erythropoietin receptor. Nature 343, 762-764.
<https://doi.org/10.1038/343762a0>
18. , T. S., Ishiguro, K., Sartorelli, A. C. (1998) Role of gp55 in restoring the sensitivity of Friend murine erythroleukaemia cells to erythropoietin by exposure to dimethyl sulfoxide. Oncology Res. 10, 175-184.
19. , M., Nishio, J., Chesebro, B. (1992) Protection against Friend retrovirus-induced leukemia by recombinant vaccinia viruses expressing the gag gene. J. Virol. 66, 4497-4507.
<https://doi.org/10.1128/jvi.66.7.4497-4507.1992>
20. , F., Ray, D., Mattei, M., Tambourin, P., Tavitian, A. (1989) The putative oncogene Spi-1: murine chromosomal localization and transcriptional activation in murine acute erythroleukaemias. Oncogene 4, 1149-1156.
21. , S. P., Pierce, C. C., Robertson, M. N., Watson ic control of spontaneous and induced immunity A. J., Montefiori, D. C., Rabin, M., Kuller, L., Thompson, J., Lynch, J. B., Morton, W. R., Benveniste, R. E., Munn, R., Hu, S. L., Greenberg, P., Haigwood, N. L. (1999) Immunization against SIV in macaques using multigenic DNA vaccines. J. Med. Primatol. 28, 206-213.
<https://doi.org/10.1111/j.1600-0684.1999.tb00271.x>
22. , M., Cheng, A., Kimura, A., Bernstein, A., Benchimol, S. (1985) Rearrangements of cellular p53 gene in erythroleukaemic cells transformed by Friend virus. Nature 314, 633-636.
<https://doi.org/10.1038/314633a0>
23. , D. G., Peacock, J. W., Benchimol, S. (1990) Inactivation of the cellular p53 is a common feature of Friend virus-induced erythroleukaemia: relationship of inactivation to dominant transforming alleles. Mol. Cell Biol. 10, 3307-3313.
24. , D. I., Hager, G. L., Chang, E. H., Scolnick, E. M., Chan, H. W., Lowy, D. R. (1980) Transfection of molecularly cloned Friend murine leukemia virus DNA yields a highly leukemogenic helper-independent type C virus. J. Virol. 33, 475-486.
<https://doi.org/10.1128/jvi.33.1.475-486.1980>
25. , R., Schuetze, S., Kozak, S. L., Kozak, C. A., Kabat, D. (1991) The Sfpi-1 proviral integration site of Friend erythroleukaemia encodes the ets-related transcription factor Pu.1. J. Virol. 65, 464-467.
<https://doi.org/10.1128/jvi.65.1.464-467.1991>
26. , J. T., Song, R., Dettenhofer, M., Tian, C., August, T., Felber, B. K., Pavlakis, G. N., Yu, X. F. (1999) Evaluation of novel HIV-1 gag DNA vaccines for protein expression in mammalian cells and induction of immune responses. J. Virol. 73, 9145-9152.
<https://doi.org/10.1128/JVI.73.11.9145-9152.1999>
27. , K. S., Lilly, F. (1991) Identification of an epitope encoded in the env gene of Friend murine leukemia virus recognized by anti-Friend virus cytotoxic lymphocytes. Virology by single cytotoxic T lymphocyte clones. Immunol. Lett. 181, 91-100.
28. , S. K. (1995) Erythroleukaemia induction by the Friend spleen focus-forming virus. Bailliere's Clinical Haematology 8, 225-247.
<https://doi.org/10.1016/S0950-3536(05)80239-2>
29. , M., Šíma, P., Ludvíková, V., Vonka, V. (2001) Modfied HPV16 E7 genes as DNA vaccine against E7containing oncogenic cells. Virology 281, 231-238.
<https://doi.org/10.1006/viro.2000.0794>
30. Teich, N., Wyke, J., Mak, T., Bernstein, A., Hardy, W. (1984) Pathogenesis of retrovirus-induced disease. In: RNA Tumor Viruses, Molecular Biology of Tumor Viruses, eds. Weiss, R., Teich, N., Varmus, H., Coffin, J., pp. 857-880, Cold Spring Harbor, New York.
31. , H., Iwanami, N., Kuribayashi, K., Tamamura, H., Fujii, N., Nakarami, T., Kavasaki, T., Yamagishi, H. (1998) Overlapping epitopes of Friend murine leukemia virus gag-encoded leader sequence recognized by single cytotoxic T lymphocyte clones. Immunol. Lett. 62, 33-38.
<https://doi.org/10.1016/S0165-2478(98)00020-0>
32. , J. B., Donnelly, J. J., Parker, S. E., Rhodes, G. H., Felgner, P. L. Dwarki, V. J., Gromkowski, S. H., Deck, R. R., de Witt, C. M., Friedman, A., Hawe, L. A., Leander, K. R., Martinez, D., Perry, H. C., Shiver, J. W., Montgomery, D. L., Liu, M. (1993) Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259, 1745-1749.
<https://doi.org/10.1126/science.8456302>
